Volume 27, Number 3—March 2021
Research
Extrapulmonary Nontuberculous Mycobacteria Infections in Hospitalized Patients, United States, 2009–2014
Emily E. Ricotta
, Jennifer Adjemian1, Rebekah A. Blakney, Yi Ling Lai, Sameer S. Kadri, and D. Rebecca Prevots
, Jennifer Adjemian1, Rebekah A. Blakney, Yi Ling Lai, Sameer S. Kadri, and D. Rebecca Prevots
Table 2
Sources of extrapulmonary nontuberculous mycobacterial infection, by site sterility and association with medical device, prosthetics, and surgery, United States, 2009–2014*
| Source | Sterile, no. (%) | Not sterile, no. (%) | Device/prosthesis associated, no. (%) | Surgery-associated, no. (%) |
|---|---|---|---|---|
| Skin and soft tissue, n = 340 |
33 (10) |
307 (90) |
59 (17) |
129 (38) |
| Disseminated, n = 290 | ||||
| Blood, n = 259 | 259 (100) | NA | 72 (28) | 26 (10) |
| Bone and joint, n = 26 | 26 (100) | NA | 7 (27) | 7 (27) |
| Central nervous system, n = 5 |
5 (100) |
NA |
3 (60) |
3 (60) |
| Other, n = 362 | ||||
| Abdominal, n = 110 | 21 (19) | 89 (81) | 27 (24) | 17 (15) |
| Urinary, n = 11 | 0 | 11 (100) | 2 (18) | 1 (9) |
| Other, n = 241 | 64 (27) | 177 (73) | 49 (20) | 87 (36) |
*Data from in Cerner Health Facts database (https://sc-ctsi.org/resources/cerner-health-facts). NA, not applicable.
1Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Page created: January 04, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.